CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,332,730 | -10.2% | 114,006 | +3.2% | 0.03% | -12.5% |
Q2 2023 | $1,484,771 | -35.8% | 110,474 | -20.8% | 0.03% | -42.9% |
Q1 2023 | $2,312,098 | +552.7% | 139,451 | +632.2% | 0.06% | +460.0% |
Q4 2022 | $354,237 | -45.0% | 19,045 | -62.0% | 0.01% | -47.4% |
Q3 2022 | $644,000 | +563.9% | 50,175 | +53.7% | 0.02% | +533.3% |
Q3 2020 | $97,000 | -70.0% | 32,653 | -53.3% | 0.00% | -70.0% |
Q2 2020 | $323,000 | -33.9% | 69,872 | -45.0% | 0.01% | -28.6% |
Q1 2020 | $489,000 | +256.9% | 126,934 | +247.6% | 0.01% | +366.7% |
Q4 2019 | $137,000 | -35.1% | 36,514 | -8.3% | 0.00% | -25.0% |
Q3 2019 | $211,000 | – | 39,820 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |